Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial - PubMed (original) (raw)

Randomized Controlled Trial

Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial

Pilar Galan et al. BMJ. 2010.

Abstract

Objective: To investigate whether dietary supplementation with B vitamins or omega 3 fatty acids, or both, could prevent major cardiovascular events in patients with a history of ischaemic heart disease or stroke.

Design: Double blind, randomised, placebo controlled trial; factorial design.

Setting: Recruitment throughout France via a network of 417 cardiologists, neurologists, and other physicians.

Participants: 2501 patients with a history of myocardial infarction, unstable angina, or ischaemic stroke.

Intervention: Daily dietary supplement containing 5-methyltetrahydrofolate (560 μg), vitamin B-6 (3 mg), and vitamin B-12 (20 μg) or placebo; and containing omega 3 fatty acids (600 mg of eicosapentanoic acid and docosahexaenoic acid at a ratio of 2:1) or placebo. Median duration of supplementation was 4.7 years.

Main outcome measures: Major cardiovascular events, defined as a composite of non-fatal myocardial infarction, stroke, or death from cardiovascular disease.

Results: Allocation to B vitamins lowered plasma homocysteine concentrations by 19% compared with placebo, but had no significant effects on major vascular events (75 v 82 patients, hazard ratio, 0.90 (95% confidence interval 0.66 to 1.23, P=0.50)). Allocation to omega 3 fatty acids increased plasma concentrations of omega 3 fatty acids by 37% compared with placebo, but also had no significant effect on major vascular events (81 v 76 patients, hazard ratio 1.08 (0.79 to 1.47, P=0.64)).

Conclusion: This study does not support the routine use of dietary supplements containing B vitamins or omega 3 fatty acids for prevention of cardiovascular disease in people with a history of ischaemic heart disease or ischaemic stroke, at least when supplementation is introduced after the acute phase of the initial event.

Trial registration: Current Controlled Trials ISRCTN41926726.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi\_disclosure.pdf and declare that they have no relationships with companies that might have an interest in the submitted work in the previous 3 years; they have no other relationships or activities that could appear to have influenced the submitted work.

Figures

Fig 1 Flow chart of study participants.

Fig 2 Effect of dietary supplementation with B vitamins on cardiovascular events and mortality (adjusted for age and sex)

Fig 3 Kaplan-Meier curves for cumulative incidence of first major cardiovascular event (non-fatal myocardial infarction, ischaemic stroke, or death from cardiovascular disease) associated with dietary supplementation with B vitamins (top) or omega 3 fatty acids (bottom)

Fig 4 Effect of dietary supplementation with omega 3 fatty acids on cardiovascular events and mortality (adjusted for age and sex)

Cited by

Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites.
O'Connell TD, Mason RP, Budoff MJ, Navar AM, Shearer GC. O'Connell TD, et al. Eur Heart J Suppl. 2020 Oct 6;22(Suppl J):J3-J20. doi: 10.1093/eurheartj/suaa115. eCollection 2020 Oct. Eur Heart J Suppl. 2020. PMID: 33061864 Free PMC article.
Very Long Chain Marine _n_-3 Polyunsaturated Fatty Acids in Atherothrombotic Heart Disease. A Brief Review, with a Focus on Metabolic Effects.
Arnesen H, Myhre PL, Seljeflot I. Arnesen H, et al. Nutrients. 2020 Sep 30;12(10):3014. doi: 10.3390/nu12103014. Nutrients. 2020. PMID: 33008057 Free PMC article. Review.
N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis.
Chen GC, Yang J, Eggersdorfer M, Zhang W, Qin LQ. Chen GC, et al. Sci Rep. 2016 Jun 16;6:28165. doi: 10.1038/srep28165. Sci Rep. 2016. PMID: 27306836 Free PMC article.
Role of Phaseolus vulgaris L. in the Prevention of Cardiovascular Diseases-Cardioprotective Potential of Bioactive Compounds.
Rodríguez L, Mendez D, Montecino H, Carrasco B, Arevalo B, Palomo I, Fuentes E. Rodríguez L, et al. Plants (Basel). 2022 Jan 11;11(2):186. doi: 10.3390/plants11020186. Plants (Basel). 2022. PMID: 35050073 Free PMC article. Review.
Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?
Kromhout D, Yasuda S, Geleijnse JM, Shimokawa H. Kromhout D, et al. Eur Heart J. 2012 Feb;33(4):436-43. doi: 10.1093/eurheartj/ehr362. Epub 2011 Sep 19. Eur Heart J. 2012. PMID: 21933782 Free PMC article. Review.

References

1. Morrison HI, Schaubel D, Desmeules M, Wigle DT. Serum folate and risk of fatal coronary heart disease. JAMA 1996;275:1893-6. - PubMed
1. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998;279:359-64. - PubMed
1. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002;287:1815-21. - PubMed
1. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346:1113-8. - PubMed
1. Erkkilä AT, Lehto S, Pyörälä K, Uusitupa MI. n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease. Am J Clin Nutr 2003;78:65-71. - PubMed

Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial - PubMed (original) (raw)